CREST trial examines durability of carotid stenosis treatments

02/6/2012 | MedPage Today (free registration)

Myriad factors contribute to the choice between stenting and surgery for patients with carotid stenosis, and research supports both options. Reblockage rates for the treatments are similar, according to a CREST trial analysis. Restenosis or occlusion after a two-year period occurred in 6% of the stent group and 6.3% among those who underwent endarterectomy.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC